Genetic risk for Alzheimer’s disease, cognition and mild behavioral impairment in healthy older adults
dc.contributor.author | Creese, B | |
dc.contributor.author | Arathimos, R | |
dc.contributor.author | Brooker, H | |
dc.contributor.author | Aarsland, D | |
dc.contributor.author | Corbett, A | |
dc.contributor.author | Lewis, C | |
dc.contributor.author | Ballard, C | |
dc.contributor.author | Ismail, Z | |
dc.date.accessioned | 2021-01-26T14:56:46Z | |
dc.date.issued | 2021-03-17 | |
dc.description.abstract | BACKGROUND: The neuropsychiatric syndrome Mild Behavioral Impairment (MBI) describes an at-risk state for dementia and may be a useful screening tool for sample enrichment. We hypothesized that stratifying a cognitively normal sample on MBI status would enhance the association between genetic risk for Alzheimer’s disease (AD) and cognition. METHODS: Data from 4,458 participants over 50 without dementia was analysed. A cognitive composite score was constructed and the MBI Checklist was used to stratify into those with MBI and those without. Polygenic scores for AD were generated using summary statistics from the IGAP study. RESULTS: AD genetic risk was associated with worse cognition in the MBI group but not in the no MBI group (MBI: β=-0.09, 95% CI: -0.13 - -0.03, p=0.002, R =0.003). The strongest association was in those with more severe MBI aged ≥65. CONCLUSIONS: MBI is an important feature of aging, screening on MBI may be a useful sample enrichment strategy for clinical research. | en_GB |
dc.description.sponsorship | National Institute for Health Research (NIHR) | en_GB |
dc.identifier.citation | Vol. 13 (1), article e12164 | en_GB |
dc.identifier.doi | 10.1002/dad2.12164 | |
dc.identifier.uri | http://hdl.handle.net/10871/124509 | |
dc.language.iso | en | en_GB |
dc.publisher | Wiley / Alzheimer's Association | en_GB |
dc.rights | © 2021 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. | |
dc.subject | mild behavioral impairment | en_GB |
dc.subject | polygenic score | en_GB |
dc.subject | Alzheimer’s disease | en_GB |
dc.subject | neuropsychiatric symptoms | en_GB |
dc.subject | cognition | en_GB |
dc.title | Genetic risk for Alzheimer’s disease, cognition and mild behavioral impairment in healthy older adults | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2021-01-26T14:56:46Z | |
dc.identifier.issn | 2352-8729 | |
dc.description | This is the final version. Available on open access from Wiley via the DOI in this record | en_GB |
dc.identifier.journal | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring | en_GB |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | en_GB |
dcterms.dateAccepted | 2021-01-26 | |
exeter.funder | ::Medical Research Council (MRC) | en_GB |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2021-01-26 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2021-01-26T14:16:56Z | |
refterms.versionFCD | AM | |
refterms.dateFOA | 2021-03-23T14:11:41Z | |
refterms.panel | A | en_GB |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2021 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association.
This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.